Real Estate [ 12/12 ] | Real Estate Management & Development [ 49/74 ]
NASDAQ | Common Stock
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States.
The company focuses to develop diagnostics and clinical laboratory services through ownership acquisition or license rights in precision diagnostic assets, genetic testing and clinical laboratory companies through joint ventures, and share ownership structures or distribution rights.
The company was founded in 2016 and is headquartered in Freehold, New Jersey.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Sep 30, 24 | -1.82 Decreased by -1.22 K% | - |
| Aug 19, 24 | -0.19 Increased by +23.45% | - |
| May 30, 24 | -0.12 Increased by +55.40% | - |
| Mar 28, 24 | -0.90 Decreased by -269.72% | - |
| Nov 14, 23 | -0.14 Decreased by -146.59% | - |
| Aug 14, 23 | -0.25 Decreased by -988.60% | - |
| May 22, 23 | -0.28 Decreased by -1.29 K% | - |
| Mar 30, 23 | -0.24 Decreased by -709.00% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 345.16 K Increased by +4.19% | -1.68 M Decreased by -13.07% | Decreased by -486.50% Decreased by -8.53% |
| Jun 30, 24 | 327.89 K Increased by +6.84% | -2.13 M Increased by +16.17% | Decreased by -650.23% Increased by +21.54% |
| Mar 31, 24 | 314.59 K Increased by +6.22% | -1.37 M Increased by +76.30% | Decreased by -434.70% Increased by +77.69% |
| Dec 31, 23 | 321.32 K Increased by +8.43% | -9.56 M Decreased by -267.21% | Decreased by -2.97 K% Decreased by -238.65% |
| Sep 30, 23 | 331.29 K Increased by +4.38% | -1.49 M Increased by +83.93% | Decreased by -448.27% Increased by +84.60% |
| Jun 30, 23 | 306.90 K Increased by +5.53% | -2.54 M Increased by +0.78% | Decreased by -828.70% Increased by +5.98% |
| Mar 31, 23 | 296.17 K Decreased by -0.49% | -5.77 M Decreased by -186.46% | Decreased by -1.95 K% Decreased by -187.88% |
| Dec 31, 22 | 296.33 K Decreased by -11.33% | -2.60 M Decreased by -11.47% | Decreased by -878.11% Decreased by -25.72% |